Skip to content

Enhancing Motor Learning with a Single Dose of Levodopa

Enhancing Motor Learning with a Single Dose of Levodopa - Improving motor learning II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46724
Enrollment
42
Registered
2018-07-02
Start date
2018-05-30
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

revalidatie na herseninfarct/bloeding n.a.

Interventions

Each participant receives once a dose of Levodopa / Carbidopa (100mg / 25mg) and once a placebo. The two intake moments are separated for at least a week.

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy Male Aged 18-55 years Informed consent obtained

Exclusion criteria

Exclusion criteria: History of neurological or psychiatric disorders History of neurosurgery History of Sleep disorders History or evidence of renal, gastrointestinal, hepatic or hematologic abnormalities Using acute or chronic psychoactive drugs Alcoholism Smoking

Design outcomes

Primary

MeasureTime frame
The main objective of the study is to determine the role of dopamine on motor learning in healthy individuals. The participants will be subjected to two different cerebellar specific motor adaptation paradigms: the inward saccade adaptation task and the visuomotor adaptation task. The motor learning capacity will be determined by quantifying the velocity and gain of adaptation. The motor timing, motor tremor, motor strength and attention task are control experiments that allow us to put the output parameters of adaptation tasks in the correct perspective.

Secondary

MeasureTime frame
n.a.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)